What is AOD 9604? AOD 9604 (Advanced Obesity Drug 9604) is a modified synthetic peptide consisting of amino acids 176-191 from the C-terminal region of human growth hormone (hGH). Developed by Metabolic Pharmaceuticals in Australia, it was specifically designed to retain the fat-burning effects of growth hormone while eliminating effects on insulin sensitivity, blood sugar regulation, and cell proliferation that can occur with full-length hGH.
What is TB-500? TB-500 is a synthetic peptide consisting of 43 amino acids, designed to mimic the active region of Thymosin Beta-4 (Tβ4), a naturally occurring protein discovered in the thymus gland. While the name TB-500 is commonly used in research circles, it's important to understand its relationship to the natural protein it replicates.
What is SLU-PP-332? SLU-PP-332 is a synthetic small molecule compound developed at Saint Louis University that acts as a potent agonist of estrogen-related receptors. Unlike most peptides we discuss, SLU-PP-332 is actually a small molecule drug, but it's grouped with research peptides due to its novel mechanism and emerging research status.
What is Semax? Semax is a synthetic heptapeptide (seven amino acids) based on a fragment of ACTH(4-10). Developed by the Institute of Molecular Genetics in Russia, it's been approved there since 1996 for treating cognitive impairments, stroke recovery, and attention disorders.